Search results
Found 11 matches for
A new study of open leg fractures suggests there is no difference to patient recovery whether high-tech negative pressure wound therapy devices are used, compared to standard dressings.
Adalimumab is found to be a cost-effective treatment for early-stage Dupuytren’s disease
15 November 2022
Researchers at the Kennedy Institute of Rheumatology and Oxford Population Health’s Health Economics Research Centre have found that anti-TNF treatment (adalimumab) is likely to be a cost-effective treatment for people affected by early-stage Dupuytren’s disease.
Gene variant links trigger finger and carpal tunnel syndrome
22 July 2022
A new NDORMS study, published in The Lancet Rheumatology, has found a genetic variant that increases the risk of both carpal tunnel syndrome and trigger finger, and opens the door for new therapies that involve blocking the IGF-1 pathway.
Yoshi Itoh wins the International Dupuytren Award 2022
30 June 2022
Yoshi Itoh, Associate Professor and Principal Investigator Cell Migration Group at the Kennedy Institute has been awarded the International Dupuytren Award 2022.
Research finds that surgery for Dupuytren’s disease is effective, but repeat operations come with higher risks
4 June 2021
Research by NDORMS Dominic Furniss, Professor of Plastic and Reconstructive Surgery, finds that surgery for the common hand disorder Dupuytren’s disease is safe and effective. However, repeat surgery could carry higher risks of complications such as finger amputation.
NDORMS researchers awarded for Dupuytren research
8 April 2021
Three NDORMS researchers have received awards from the International Dupuytren Society, a patient organisation that brings together Dupuytren Disease patient societies from across the world.
NDORMS team awarded the International Dupuytren Award
12 November 2019
Jagdeep Nanchahal, Professor of Hand, Plastic and Reconstructive Surgery at the Kennedy Institute, and his team have won the International Dupuytren Award for a trial repurposing anti-TNF in Dupuytren’s disease.
Meet the team
-
Matthew Costa
Professor of Orthopaedic Trauma Surgery
Read the paper
In The Journal of the American Medical Association (JAMA)
Professor Matt Costa talks about the study
More information
- Conducted by Warwick Clinical Trials Unit, the University of Warwick, University Hospitals Coventry and Warwickshire NHS Trust, and NDORMS
- Results have implications for patients' recovery and healthcare costs
- This project was funded by the UK NIHR HTA Programme (project No. 10/57/20) and was supported by the NIHR Oxford Biomedical Research Centre and the NIHR Collaboration for Leadership in Applied Health Research and Care in Oxford. The 2 main commercial entities (Smith & Nephew and KCI Medical) in this sector funded the excess treatment costs of the negative pressure wound therapy dressings but had no part in the design, conduct, or reporting of the trial.